Recent Grants Awarded

Global Healing


Global Healing was awarded a three year, $50,000 grant in support of the project, Patients First: Uniting Quality Systems and Clinical Management of Blood Transfusions.

This program will create a robust hospital blood transfusion service that will provide safe blood products to transfusion recipients at the Mirebalais National Teaching Hospital in Haiti.  The program will allow Global Healing to (1) establish a quality assurance department in order to adhere to internationally accepted transfusion medicine standards, and (2) provide medical education to the personnel involved in the clinical use of blood. Global Healing’s training will allow patient care to be on par with developed countries. Following the program’s establishment, and because of its status as a national teaching hospital, the standard of care for transfusion recipients at the Mirebalais National Teaching Hospital will expand throughout Haiti. This process of generational education will allow Haitian physicians and nurses to initially save the lives of countless mothers and children and eventually provide world class care to severe trauma patients, never before available in the country. Based on previous successful transfusion programs, Global Healing has projected that it will take three years to achieve both the technical and educational objectives.

Overall Goal

The overall goal of this project is to promote evidence-based transfusion medicine at the Mirebalais National Teaching Hospital in Haiti, supported through continuous feedback from quality assurance systems within the blood transfusion service.


Burkina Faso

Jhpeigo was awarded a one-year, $100,000 grant in support of the program, Fighting Cervical Cancer to Improve Women’s Health in Burkina Faso.

Cervical Cancer Prevention (CECAP) services are targeted to women 25–50 years old. In Burkina Faso, there are approximately 3.75 million women of reproductive age (15–49), accounting for 23% of the population, who could benefit from increased access to CECAP services. The progressive expansion of screening and treatment services in the last two years is an important step toward achieving public health impact in reducing the burden of cervical cancer in Burkina Faso. Based on the experience of the previous two-year partnership with the IZUMI Foundation, Jhpiego has identified three key activities to further solidify routine cervical cancer screening services in Burkina Faso’s public hospitals: (1) increase local capacity to supervise and monitor services, (2) increase local capacity for maintenance of cryotherapy equipment, and (3) analyze CECAP service delivery costs to better inform the Burkinabè cost recovery structure.

Overall Goal

The goal of the project is to reduce the burden of cervical cancer among women in Burkina Faso through increased access to cervical cancer prevention services.

ORBIS International


ORBIS International was awarded a two-year, $100,000 grant in support of the project, Elimination of Blindness and Visual Impairment due to Trachoma in Gamo Gofa Zone, Konso and Derashe Special Woredas, Southern Ethiopia.

ORBIS is carrying out a comprehensive, multi-year project (2007-2015) for trachoma elimination and vision care development in southern Ethiopia where trachoma is hyper-endemic across its catchment population of 2.2 million people.  In partnership with local health, education, and economic bureaus and WaterAid Ethiopia, and with significant antibiotic contributions from Pfizer through the International Trachoma Initiative, ORBIS is implementing the World Health Organization-recommended SAFE (Surgery, Antibiotic, Face Washing and Environmental Hygiene) strategy for the elimination of trachoma. ORBIS is also addressing other major causes of blindness such as cataract and refractive error in the region.

Overall Goal

The project aims to reduce the prevalence of active trachoma to below 10% and the prevalence of trichiasis to below 1% in Gamo Gofa Zone, Konso and Derashe Special Woredas by 2015, implementing the WHO-recommended full SAFE strategy.